Remarkably, several in vitro and in vivo studies have indeed identified several peptides or small molecule inhibitors of CXCR4 able to inhibit BC growth and progression dramatically [273,274,275,276,277,278,279]. This evidence concerns the gene CXCR4 and breast cancer.